Clinical Research Directory

Inclusion Criteria: * Patients aged 18 years or older. * Patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES). * Patients with the following clinical indications for PCI: * Unstable Angina: Prolonged chest pain at rest, new-onset angina within the past 2 months, or increasing frequency/severity of angina attacks. * Acute Myocardial Infarction (MI): With or without ST-elevation. * Chronic Coronary Syndrome: Requiring coronary revascularization. * Patients who agree to participate and provide informed consent. Exclusion Criteria: * Inability to Provide Informed Consent: Patients who are unable or unwilling to provide consent. * Neurological Complications: Stroke or any permanent neurological deficits within the last 3 months. * Coronary Artery Bypass Graft Surgery: History of CABG surgery. * Planned Surgery: Patients who have surgeries planned within the next 12 months. * Severe Chronic Kidney Disease: Patients with an estimated glomerular filtration rate (eGFR) of less than 20 ml/min/1.73 m² or patients on dialysis. * Chronic Anticoagulation Therapy: Patients requiring chronic oral anticoagulation (e.g., warfarin, DOACs) beyond DAPT. * Thrombocytopenia: Platelet count less than 100,000/mm³. * Contraindications to Antiplatelet Therapy: Allergy or intolerance to aspirin or P2Y12 inhibitors. * Liver Disease: Patients with cirrhosis or significant liver dysfunction. * Limited Life Expectancy: Patients with a life expectancy of less than 12 months due to other non-cardiac conditions. * Other Medical Conditions: Any condition that might interfere with adherence to the study protocol or follow-up schedule.